1. Effect of Vasopressin on the Hypothalamic-Pituitary-Adrenal Axis in ADPKD Patients during V2 Receptor Antagonism

   Heida, J. E., Minović, I., van Faassen, M., Kema, I. P., Boertien, W. E., Bakker, S. J. L., van Beek, A. P. & Gansevoort, R. T., 4-Nov-2020, In : American Journal of Nephrology. p. 1-10 10 p., 000511000.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Urine-to-plasma urea ratio, as surrogate marker for urine concentrating capacity, is associated with disease progression in adpkd

   Heida, J. E., Gansevoort, R., Messchendorp, L., Meijer, E., Casteleijn, N. F., Boertien, W. E. & Zittema, D., Jun-2020, In : Nephrology Dialysis Transplantation. 35, p. 97 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. No Change in Nocturia After NOCTURNE

   Meijer, E., Heida, J. E. & Gansevoort, R. T., Jun-2020, In : Kidney International Reports. 5, 6, p. 762-765 4 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Use of copeptin in the diagnosis of polyuria-polydipsia syndrome

   Heida, J. E., Gansevoort, R. T. & van Beek, A. P., 25-Jan-2020, In : The Lancet. 395, 10220, p. 267 1 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

5. Determinants of urine volume in adpkd-patients using the vasopressin v2 receptor antagonist tolvaptan

   Kramers, B., Heida, J., Boertien, W., van Gastel, M., Meijer, E. & Gansevoort, R., May-2018, In : Nephrology Dialysis Transplantation. 33, 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (7) »